QT intervals during parenteral nutrition
6. Peters R.W., Byington R.P., Barker A., Yusuf S. BHAT Study
Group. Prognostic value of prolonged ventricular repolarization
following myocardial infarction: The BHAT experience. J. Clin.
Epidemiol. 1990, 43: 167-172.
in a better long-term survival of diabetic patients (15).
Moreover, the use of intensive insulin therapy to maintain
blood glucose at a level that did not exceed 110 mg per
deciliter substantially reduced mortality in the intensive care
unit, in-hospital mortality, and morbidity among critically ill
patients admitted to intensive care unit (16). Previous ex-
periments involving dogs adapted to total parenteral nutri-
tion demonstrated that the administration of electrolytes,
insulin and glucose corrected the dysrhythmia, which did
not recur (17). Experimental and clinical data demonstrat-
ing the antiarrhythmic effect of electrolytes supplementa-
tion are recalled (18). The electrophysiological explanation
is based on the inhibition of potassium and calcium flow
across the cell membrane: in particular magnesium ion has
a stabilizing membrane effect and an antagonistic effect on
ectopic automaticity. Electrolyte supplementations are par-
ticularly important on slowly depolarizing tissue (nodal cells)
or partially depolarized cells (ischemic or digitalis treated
cardiac tissue) (18). In conclusion, the infusion of triacyl-
glycerol emulsion as a source of fat and calories in critical-
ly ill patients seems to be safe when planned in the setting
of a balanced parenteral nutrition. In this context, glucose,
insulin and electrolytes may preserve the heart from the
electrical perturbations derived by the raised plasma free
fatty acid concentrations.
7. Marfella R., De Angelis L., Nappo F., et al. Elevated plasma free
fatty acid concentrations prolong cardiac repolarization in
healthy subjects. Am. J. Clin. Nutr. 2001, 73: 27-30.
8. Parati G., Casadei A., Groppelli M., Di Rienzo M., Mancia G.
Comparison of finger and intra-arterial blood pressure moni-
toring at rest and during laboratory testing. Hypertension 1989,
13: 647-655.
9. Bazett H.C. An analysis of time relations of the electrocardio-
gram. Heart. 1920, 7: 353-370.
10. Dole V.P., Meinertz H. Microdetermination of long-chain fatty
acid in plasma and tissues. J. Biol. Chem. 1960, 235: 2595-2599.
11. Ahnve S., Vallin H. Influence of heart rate and inhibition of au-
tonomic tone on the QT interval. Circulation 1982, 65: 435-
439.
12. Barr C.S., Nans A., Freeman M., Lang C., Struthers A.D. QT dis-
persion and sudden unexpected death in chronic heart failure.
Lancet 1994, 343: 327-329.
13. Vlay S.C., Mallis G.L., Brown E.J., Cohon P.F. Documented sud-
den cardiac death in prolonged QT syndrome. Arch. Intern.
Med. 1984, 144: 833-834.
14. Stojiljkovic M.P., Zhang D., Lopes H.F., Lee C.G., Goodfriend
T.L., Egan B.M. Hemodynamic effects of lipids in humans. Am. J.
Physiol. Regul. Integr. Comp. Physiol. 2001, 280: R1674-R1679.
REFERENCES
15. Malmberg K., Ryden L., Efendic S., et al. Randomised trial of in-
sulin-glucose infusion followed by subcutaneous insulin treat-
ment in diabetic patients with acute myocardial infarction
(DIGAMI study): effects on mortality at 1 year. J. Am. Coll.
Cardiol. 1995, 26: 57-65.
1. Souba W. Nutritional support. N. Engl. J. Med. 1997, 336: 41-48.
2. Leak D. Intravenous amiodarone in the treatment of refractory
life-threatening cardiac arrhythmias in the critically ill patient.
Am. Heart J. 1986, 111: 456-462.
16. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin
therapy in critically ill patients. N. Engl. J. Med. 2001, 345: 1359-
1367.
3. Paolisso G., Gualdiero P., Manzella D., et al. Association of fast-
ing plasma FFA concentration and frequency of ventricular pre-
mature complexes in non-ischemic non-insulin dependent dia-
betic patients. Am. J. Cardiol. 1997, 80: 932-937.
17. Donmoyer C.M., Chen S., Hande S.A., Brooks Lacy D., Ejiofor
J., McGuinness O.P. Hyperinsulinemia compensates for infec-
tion-induced impairment in net hepatic glucose uptake during
TPN. Am. J. Physiol. 2000, 279: E235-E243.
4. Jouven X., Charles M.A., Desnos M., et al. Circulating nones-
terified fatty acid level as a predictive risk factor for sudden death
in the population. Circulation 2001, 104: 756-761.
5. Zipes D.P. Specific arrhythmias: diagnosis and treatment. In:
Braunwald E., (Ed.), Heart Disease. A Textbook of Cardio-
vascular Medicine: W.B. Saunders, Philadelphia,1997, p. 640-704.
18. Marsepoil T., Blin F., Hardy F., Letessier G., Sebbah J.L. Torsades
de pointes and hypomagnesemia. Ann. Fr. Anesth. Reanim.1985,
4: 524-526.
RC22